Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Iressa Versus Docetaxel (Taxotere)

ClinicalTrials.gov ID: NCT00076388

Public ClinicalTrials.gov record NCT00076388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effects of ZD1839 or docetaxel in patients with advanced non-small cell lung cancer (NSCLC) that has recurred or progressed after receiving prior treatment with platinum-based chemotherapy.

Study identification

NCT ID
NCT00076388
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,440 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2004 (Type not available)
Primary completion
Mar 2007 (Actual)
Completion
Oct 2007 (Actual)
Last update posted
May 13, 2011

2004 – 2007

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site Fountain Valley California — —
Research Site Los Angeles California 90048 —
Research Site Santa Rosa California — —
Research Site Stockton California 95204 —
Research Site Colorado Springs Colorado — —
Research Site Norwich Connecticut — —
Research Site Newark Delaware — —
Research Site Boca Raton Florida — —
Research Site Orlando Florida 32806 —
Research Site Macon Georgia — —
Research Site Tucker Georgia — —
Research Site Skokie Illinois 60077 —
Research Site Knoxville Kentucky — —
Research Site Saint Louis Park Minnesota — —
Research Site Great Neck New York 11021 —
Research Site Rochester New York 14621 —
Research Site Syracuse New York 13210 —
Research Site Chapel Hill North Carolina 27599 —
Research Site Charlotte North Carolina — —
Research Site Durham North Carolina 27710 —
Research Site Cleveland Ohio 44195 —
Research Site Portland Oregon — —
Research Site Philadelphia Pennsylvania — —
Research Site Pittsburgh Pennsylvania — —
Research Site Columbia South Carolina — —
Research Site Nashville Tennessee — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Houston Texas 77030-4009 —
Research Site Tyler Texas — —
Research Site Salt Lake City Utah — —
Research Site Fairfax Virginia — —
Research Site Seattle Washington — —
Research Site Racine Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00076388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2011 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00076388 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →